3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Recruiting
2
Sponsor Class
OTHER
39
INDUSTRY
11
NIH
4
OTHER_GOV
2
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Breast Neoplasms
49
Prostatic Neoplasms
38
Carcinoma, Non-Small-Cell Lung
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Neoplasms
23
Multiple Myeloma
22
Lymphoma
21
Leukemia, Myeloid, Acute
17
Colorectal Neoplasms
17
Melanoma
15
Lung Neoplasms
13
Hodgkin Disease
11
Brain Neoplasms
11
Medulloblastoma
10
Lymphoma, Non-Hodgkin
10
Glioblastoma
10
Squamous Cell Carcinoma of Head and Neck
9
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Leukemia, Biphenotypic, Acute
9
Leukemia
9
Head and Neck Neoplasms
9
HIV Infections
9
Neuroblastoma
8
Hematologic Neoplasms
8
Ependymoma
8
Glioma
7
Carcinoma, Renal Cell
7
Astrocytoma
7
Wilms Tumor
6
Interventions
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Peritoneal Neoplasms
×
1 year
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled
NCT04111978
2025-09-29
MATAO
Swiss GO Trial Group
Phase 3
Recruiting
540 enrolled